• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

EU and China cooperation dialogue for STI

On 9 April, the fourth Innovation Cooperation Dialogue, co-chaired by the European Commissioner for Research, Science and Innovation, Carlos Moedas and the...

find out more ›

Stryker joins the Avicenna Alliance

The Avicenna Alliance is proud to announce the newest addition to its list of members: Stryker. Stryker is one of the world’s leading medical technology companies...

find out more ›

FEops HEARTguideTM receives CE mark

The Avicenna Alliance Secretariat is proud to announce that one of its members, FEops, has received the ‘CE’ mark for its FEops HEARTguideTM.

The CE marking...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes